Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Medtronic
US Department of Justice
Mallinckrodt
McKinsey
Johnson and Johnson
Julphar
Argus Health

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DORIPENEM

« Back to Dashboard

Clinical Trials for Doripenem

Trial ID Title Status Sponsor Phase Summary
NCT00210938 Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed Peninsula Pharmaceuticals, Inc. Phase 3 The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections.
NCT00210938 Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections.
NCT00210990 Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed Peninsula Pharmaceuticals, Inc. Phase 3 The purpose of this study is to assess the microbiological cure rate of doripenem in the treatment of patients with complicated urinary tract infection or pyelonephritis. The study will also characterize the safety and tolerability of treatment with doripenem in patients with complicated urinary tract infection or pyelonephritis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Doripenem

Condition Name

Condition Name for Doripenem
Intervention Trials
Urinary Tract Infections 5
Pneumonia 5
Ventilator-Associated Pneumonia 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Doripenem
Intervention Trials
Infection 15
Communicable Diseases 13
Pneumonia 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Doripenem

Trials by Country

Trials by Country for Doripenem
Location Trials
United States 67
Argentina 7
Ukraine 6
Russian Federation 5
Canada 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Doripenem
Location Trials
Ohio 7
Michigan 7
California 6
Arkansas 4
District of Columbia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Doripenem

Clinical Trial Phase

Clinical Trial Phase for Doripenem
Clinical Trial Phase Trials
Phase 4 8
Phase 3 12
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Doripenem
Clinical Trial Phase Trials
Completed 22
Terminated 5
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Doripenem

Sponsor Name

Sponsor Name for Doripenem
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 8
Peninsula Pharmaceuticals, Inc. 6
Janssen Research & Development, LLC 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Doripenem
Sponsor Trials
Industry 29
Other 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cerilliant
Covington
Queensland Health
UBS
Merck
Daiichi Sankyo
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.